Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma
Cancer Medicine · 2023
DOI: 10.1002/cam4.5731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Xuejun Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Tertiary Lymphoid Structures, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
We investigated the clinical implications and molecular features of TLS in stage I lung adenocarcinoma (LUAD).
Methods
We retrospectively reviewed the clinicopathological characteristics of 540 patients with p ‐stage I LUAD. Logistic regression analysis was applied to determining the relationships between clinicopathological features and the presence of TLS. TLS‐associated immune infiltration pattern and signature genes were characterized using the transcriptomic profiles of 511 LUADs from The Cancer Genome Atlas (TCGA) database.
Results
The presence of TLS was associated with a higher pT stage, low‐ and middle‐grade patterns, and the absence of tumor spreading through air spaces (STAS) and subsolid nodules. Multivariate Cox regression analysis identified that the presence of TLS was associated with favorable overall survival (OS) ( p < 0.001) and recurrence‐free survival (RFS) ( p < 0.001). Subgroup analysis showed that the most favorable OS ( p < 0.001) and RFS ( p < 0.001) favored the TLS + PD‐1‐ subgroup. The presence of TLS was characterized by abundance in antitumor immunocytes including activated CD8+ T and B cells as well as dentritic cells in TCGA cohort.
Conclusion
The presence of TLS was an independent favorable factor for patients with stage I LUAD. The presence TLS was featured by special immune profiles which might aid oncologists in determining personalized adjuvant treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Yongbing Chen, Donglai Chen
Zitieren
APA
Xu, X., Gao, Y., Duan, S., Ding, Q., Wang, X., Dai, X., Zhang, Y., Chen, Y., & Chen, D. (2023). Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.5731
Vancouver
Xu X, Gao Y, Duan S, Ding Q, Wang X, Dai X, et al. Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma. Cancer Medicine. 2023. doi:10.1002/cam4.5731
BibTeX
@article{Xu2023,
author = {Xu, Xuejun and Gao, Yifeng and Duan, Shanzhou and Ding, Qifeng and Wang, Xiaofan and Dai, Xiaoxiao and Zhang, Yongsheng and Chen, Yongbing and Chen, Donglai},
title = {Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5731}
}
EUVIMED